Research Project
Grant-in-Aid for Challenging Exploratory Research
To target an oncogene in clinical setting, it is important to develop effective drug discovery based on the accurate information in epigenome. In the present study, the histone demethylating enzyme controlled by oncogene c - MYC was identified as a target candidate by using the comprehensive transcriptome analysis method. As a result, it was shown that histone methylation modification system was important and that NO66 played an important role in gastrointestinal cancer as its target. Furthermore we showed that it was possible to overcome refractory cancer by drug discovery targeting MYC - NO 66, for which we constructed the foundation.
All 2018 2017 2016
All Journal Article (11 results) (of which Int'l Joint Research: 1 results, Peer Reviewed: 11 results, Open Access: 11 results) Presentation (4 results)
Sci. Rep.
Volume: 8 Issue: 1 Pages: 899-899
10.1038/s41598-018-19284-3
Volume: 8 Issue: 1 Pages: 303-303
10.1038/s41598-017-18456-x
Int. J. Oncol.
Volume: 52 Pages: 621-629
10.3892/ijo.2017.4219
Volume: 50 Issue: 4 Pages: 1057-1063
10.3892/ijo.2017.3885
Ann. Surg. Oncol.
Volume: 24 Issue: 8 Pages: 2344-2352
10.1245/s10434-017-5871-x
Volume: 52 Pages: 453-460
10.3892/ijo.2017.4218
Oncotarget.
Volume: 9 Issue: 7 Pages: 7476-7486
10.18632/oncotarget.23554
Oncol. Rep.
Volume: 39 Pages: 1276-1282
10.3892/or.2017.6172
Volume: 24 Issue: 3 Pages: 841-849
10.1245/s10434-016-5395-9
Sci. Rep
Volume: 6 Issue: 1 Pages: 36289-36289
10.1038/srep36289
Cancer Chemother Pharmacol.
Volume: 78 Issue: 2 Pages: 389-396
10.1007/s00280-016-3080-0